Skip to Content
Merck
  • Identification of differentiation-stage specific markers that define the ex vivo osteoblastic phenotype.

Identification of differentiation-stage specific markers that define the ex vivo osteoblastic phenotype.

Bone (2014-07-02)
Natalie A Twine, Li Chen, Chi N Pang, Marc R Wilkins, Moustapha Kassem
ABSTRACT

The phenotype of osteoblastic (OB) cells in culture is currently defined using a limited number of markers of low sensitivity and specificity. For the clinical use of human skeletal (stromal, mesenchymal) stem cells (hMSC) in therapy, there is also a need to identify a set of gene markers that predict in vivo bone forming capacity. Thus, we used RNA sequencing to examine changes in expression for a set of skeletally-related genes across 8 time points between 0 and 12days of ex vivo OB differentiation of hMSC. We identified 123 genes showing significant temporal expression change. Hierarchical clustering and Pearson's correlation generated 4 groups of genes: early stage differentiation genes (peak expression: 0-24h, n=28) which were enriched for extracellular matrix organisation, e.g. COL1A1, LOX, and SERPINH1; middle stage differentiating genes (peak expression days: 3 and 6, n=20) which were enriched for extracellular matrix/skeletal system development e.g. BMP4, CYP24A1, and TGFBR2; and late stage differentiation genes (peak expression days: 9 and 12, n=27) which were enriched for bone development/osteoblast differentiation, e.g. BMP2 and IGF2. In addition, we identified 13 genes with bimodal temporal expression (2 peaks of expression: days 0 and 12) including VEGFA, PDGFA and FGF2. We examined the specificity of the 123 genes' expression in skeletal tissues and thus propose a set of ex vivo differentiation-stage-specific markers (n=21). In an independent analysis, we identified a subset of genes (n=20, e.g. ELN, COL11A1, BMP4) to predict the bone forming capacity of hMSC and another set (n=20, e.g. IGF2, TGFB2, SMAD3) associated with the ex vivo phenotype of hMSC obtained from osteoporotic patients.

MATERIALS
Product Number
Brand
Product Description

Supelco
Dexamethasone, VETRANAL®, analytical standard
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
1α,25-Dihydroxyvitamin D3, ≥99% (HPLC)
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Dexamethasone, tested according to Ph. Eur.
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
1α,25-Dihydroxyvitamin D2 solution, 50 μg/mL in ethanol, 95% (CP)
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Dexamethasone, powder, BioReagent, suitable for cell culture, ≥97%
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Dexamethasone, powder, γ-irradiated, BioXtra, suitable for cell culture, ≥80% (HPLC)
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
1α,25-Dihydroxyvitamin D3, ≥97.0% (HPLC)
SKU
Pack Size
Availability
Price
Quantity
Supelco
Ascorbic Acid, Pharmaceutical Secondary Standard; Certified Reference Material
SKU
Pack Size
Availability
Price
Quantity
Dexamethasone, European Pharmacopoeia (EP) Reference Standard
SKU
Pack Size
Availability
Price
Quantity
Supelco
1α,25-Dihydroxyvitamin D2 solution, 5 μg/mL in ethanol, ampule of 1 mL, certified reference material, Cerilliant®
SKU
Pack Size
Availability
Price
Quantity
USP
Dexamethasone, United States Pharmacopeia (USP) Reference Standard
SKU
Pack Size
Availability
Price
Quantity
Ascorbic acid, European Pharmacopoeia (EP) Reference Standard
SKU
Pack Size
Availability
Price
Quantity
Dexamethasone, British Pharmacopoeia (BP) Assay Standard
SKU
Pack Size
Availability
Price
Quantity
Dexamethasone for system suitability, European Pharmacopoeia (EP) Reference Standard
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
1α,25-Dihydroxyvitamin D2 solution, 100 μg/mL in ethanol, 95% (CP)
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Dexamethasone, meets USP testing specifications
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Dexamethasone, ≥98% (HPLC), powder
SKU
Pack Size
Availability
Price
Quantity
Supelco
Dexamethasone, Pharmaceutical Secondary Standard; Certified Reference Material
SKU
Pack Size
Availability
Price
Quantity
USP
Ascorbic acid, United States Pharmacopeia (USP) Reference Standard
SKU
Pack Size
Availability
Price
Quantity
Supelco
L-Ascorbic acid, analytical standard
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
L-Ascorbic acid, suitable for cell culture, suitable for plant cell culture, ≥98%
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
L-Ascorbic acid, powder, suitable for cell culture, γ-irradiated
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
L-Ascorbic acid, BioUltra, ≥99.5% (RT)
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
L-Ascorbic acid, puriss. p.a., ACS reagent, reag. ISO, Ph. Eur., 99.7-100.5% (oxidimetric)
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
L-Ascorbic acid, puriss. p.a., ≥99.0% (RT)
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
L-Ascorbic acid, tested according to Ph. Eur.
SKU
Pack Size
Availability
Price
Quantity
Calcitriol, European Pharmacopoeia (EP) Reference Standard
SKU
Pack Size
Availability
Price
Quantity
Dexamethasone for peak identification, European Pharmacopoeia (EP) Reference Standard
SKU
Pack Size
Availability
Price
Quantity
Supelco
L-Ascorbic acid, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
L-Ascorbic acid, FCC, FG
SKU
Pack Size
Availability
Price
Quantity